![]() |
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | |
England and Wales High Court (Queen's Bench Division) Decisions |
||
You are here: BAILII >> Databases >> England and Wales High Court (Queen's Bench Division) Decisions >> Mays v Drive Force (UK) Ltd [2019] EWHC 5 (QB) (04 January 2019) URL: http://www.bailii.org/ew/cases/EWHC/QB/2019/5.html Cite as: [2019] EWHC 5 (QB) |
[New search] [Printable PDF version] [Help]
QUEEN'S BENCH DIVISION
Strand, London, WC2A 2LL |
||
B e f o r e :
____________________
STEPHEN MAYS (a Protected Party by his Litigation Friend, the Official Solicitor) |
Claimant |
|
-and- |
||
DRIVE FORCE (UK) LIMITED |
Defendant |
____________________
Ronald Walker QC (for the Defendant)
Hearing date: 5 December 2018
____________________
Crown Copyright ©
DEPUTY MASTER HILL QC:
Introduction
The Defendant's submissions
(i) If a Claimant has co-morbid conditions in addition to the index event that affect his life expectancy, the Court should have access to expert evidence on the issue. This was accepted by the Court of Appeal in Royal Victoria Infirmary and Associated Hospitals NHS Trust v B (a child) [2002] PIQR Q10 and is an approach that has been followed in other cases such as Sarwar v Ali [2007] EWHC 274 (QB) (Lloyd-Jones J), Burton v Kingsbury [2007] EWHC 2091 (QB) (Flaux J) and Lewis v Royal Shrewsbury Hospital NHS Trust [2007] 1 WLUK 628 (Sir Alistair MacDuff);
(ii) There are a range of factors in the Claimant's case which are potentially relevant to his life expectancy other than the accident itself. The Consultant Neurologists already instructed by the parties have both acknowledged this. Moreover, while the Defendant's Consultant Neurologist, Dr Oliver Foster, has given a view on the impact of the Claimant's smoking on his life expectancy, he made clear that he would defer to another expert on the issue of the impact of his ulcerative colitis on his life expectancy. He has also indicated that "such reductions in life expectancy are not strictly additive and I would defer to life expectancy expertise with regard to quantification of his overall reduction in life expectancy". Accordingly, the Neurologists are not able to fully address the life expectancy issue;
(iii) In contrast, in his report dated 21 June 2017, Professor Bowen-Jones has considered the impact on the Claimant's life expectancy of his cigarette smoking, his hypertension, his obesity and his colitis. Adopting a statistical approach, he has assessed the Claimant's life expectancy ignoring the epilepsy risk to age 73.5, which would represent a reduction of approximately 11 years. This is therefore a significant issue which could substantially affect the future loss element of the claim and the Defendant is entitled to rely on this evidence; and
(iv) Professor Bowen-Jones has not examined the Claimant personally but has a clinical background and an expertise in statistics, and is qualified to give this evidence. He has provided evidence in at least one other case, Wolstenholme v Leach's of Shudehill Ltd [2016] EWHC 588 (QB). Any challenges to his expertise or ability to give reliable evidence are matters for the trial judge.
The Claimant's submissions
(i) The cases referred to by the Defendant do not support common practice of permitting life expectancy evidence to deal with matters extraneous to the tort. Life expectancy is generally treated as a clinical matter. In the cases relied on by the Defendant the life expectancy evidence generally came from clinicians: in Sarwar and Burton, for example, which were both cases involving tetraplegia, the experts were both spinal injury surgeons;
(ii) Separate statistical evidence is normally reserved for cases in which the clinical experts interpret the data in a fundamentally different way;
(iii) Matters such as smoking and mild hypertension are common conditions and the Consultant Neurologists instructed by each party are best placed to consider the impact of these factors on the Claimant's life expectancy evidence;
(iv) If Professor Bowen-Jones' evidence is permitted in this case, it would be to permit a hitherto uncommon practice of permitting life expectancy evidence to deal with non-accident factors. It would lead to him or a similar expert being instructed in all cases, and this would be contrary to the good administration of justice;
(v) Professor Bowen-Jones' statistical approach derives from the insurance context and is not necessarily validated in personal injury claims; and
(vi) His evidence contains a good deal of speculation around issues such as whether the Claimant's obesity would have necessitated retirement from HGV driving at aged 60.
Discussion and conclusions